バイオチップの世界市場分析:タイプ別(DNAチップ、ラボオンチップ、タンパク質チップ、がん診断および治療、遺伝子発現、一塩基多型(SNP)遺伝子型決定、ゲノミクス、薬物発見、農業バイオテクノロジー、プロテオミクス、発現プロファイリング、ハイスループットスクリーニング)、エンドユーザー別別(バイオテクノロジー・製薬企業、病院&診断センター、学術&研究機関)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Biochip Market Analysis by Type, (DNA Chips, Lab-On-a-Chip, Protein Chips, Cancer Diagnosis and Treatment, Gene Expression, Single Nucleotide Polymorphism (SNP) Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes), and Segment Forecasts to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Biochip Industry Outlook
3.1 Market Segmentation
3.2 Market Size and Growth prospects, 2013 – 2024
3.3 Biochip Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increase in adoption of next-generation sequencing
3.3.1.2 Growing R&D in proteomics and genomics
3.3.1.3 Presence of an extensive drug-development pipeline
3.3.1.4 Increasing adoption of personalized medicine
3.3.1.5 Rapid technological advances in biochip technology
3.3.2 Market restraint analysis
3.3.2.1 High cost of manufacturing
3.4 Key Opportunities Prioritized,2015
3.6 Industry Analysis – Porter’s
3.7 Biochip PESTEL Analysis
Chapter 4 Biochip Type Outlook
4.1 Global Biochip Revenue Share, by Product, 2015 & 2024
4.2 DNA Chips, by Application
4.2.1 DNA chips market, 2013 – 2024 (USD Million)
4.2.2 Cancer diagnosis and treatment
4.2.2.1 Cancer diagnosis and treatment market, 2013 – 2024 (USD Million)
4.2.3 Gene expression
4.2.3.1 Gene expression market, 2013 – 2024 (US Million)
4.2.4 Single nucleotide polymorphism (SNP) genotyping
4.2.4.1 SNP genotyping market, 2013 – 2024 (USD Million)
4.2.5 Genomics
4.2.5.1 Genomics market, 2013 – 2024 (USD Million)
4.2.6 Drug discovery
4.2.6.1 Drug discovery market, 2013 – 2024 (USD Million)
4.2.7 Agricultural biotechnology
4.2.7.1 Agricultural biotechnology market, 2013 – 2024 (USD Million)
4.2.8 Others
4.2.8.1 Other markets, 2013 – 2024 (USD Million)
4.3 Lab-On-a-Chip, by Application
4.3.1 Lab-on-a-chip market, 2013 – 2024 (USD Million)
4.3.2 Clinical diagnostics
4.3.2.1 Clinical diagnostics market, 2013 – 2024 (USD Million)
4.3.3 Genomics
4.3.3.1 Genomics market, 2013 – 2024 (USD Million)
4.3.4 In vitro diagnosis (IVD) & point-of-care (POC)
4.3.4.1 IVD & POC market, 2013 – 2024 (USD Million)
4.3.5 Proteomics
4.3.5.1 Proteomics market, 2013 – 2024 (USD Million)
4.3.6 Drug discovery
4.3.6.1 Drug discovery market, 2013 – 2024 (USD Million)
4.3.7 Others
4.3.7.1 Others market, 2013 – 2024 (USD Million)
4.4 Protein Chips, by Application
4.4.1 Protein chips market, 2013 – 2024 (USD Million)
4.4.2 Proteomics
4.4.2.1 Proteomics market, 2013 – 2024 (USD Million)
4.4.3 Expression profiling
4.4.3.1 Expression profiling market, 2013 – 2024 (USD Million)
4.4.4 Diagnostics
4.4.4.1 Diagnostics market, 2013 – 2024 (USD Million)
4.4.5 High Throughput Screening (HTS)
4.4.5.1 HTS market, 2013 – 2024 (USD Million)
4.4.6 Drug discovery
4.4.6.1 Drug discovery market, 2013 – 2024 (USD Million)
4.4.7 Others
4.4.7.1 Others market, 2013 – 2024 (USD Million)
4.5 Others
4.5.1 Other market, 2013 – 2024 (USD Million)
4.5.2 Tissue arrays
4.5.2.1 Tissue arrays market, 2013 – 2024 (USD Million)
4.5.3 Cell arrays
4.5.3.1 Cell arrays market, 2013 – 2024 (USD Million)
Chapter 5 Biochip End-Use Outlook
5.1 Global Biochip Revenue Share by End Use, 2015 & 2024
5.2 Biotechnology and Pharmaceutical Companies
5.2.1 Biotechnology and pharmaceutical companies market, 2013 – 2024 (USD Million)
5.3 Hospitals and Diagnostics Centers
5.3.1 Hospitals and diagnostics centers market, 2013 – 2024 (USD Million)
5.4 Academic & Research Institutes
5.4.1 Academic & research institutes market, 2013 – 2024 (USD Million)
5.5 Others
5.5.1 Others market, 2013 – 2024 (USD Million)
Chapter 7 Biochip Regional Outlook
7.1 Global Biochip Revenue Share, By Region, 2015&2024
7.2 North America
7.2.1 North America biochip market, 2013 – 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. biochip market, 2013 – 2024 (US Million)
7.2.3 Canada
7.2.3.1 Canada biochip market, 2013 – 2024 (US Million)
7.3 Europe
7.3.1 Europe biochip market, 2013 – 2024 (USD Million)
7.3.2 Germany
7.3.2.1 Germany biochip market, 2013 – 2024(USD Million)
7.3.3 UK
7.3.3.1 UK biochip market, 2013 – 2024 (US Million)
7.4 Asia Pacific
7.4.1 Asia Pacific biochip market, 2013 – 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japan biochip market, 2013 – 2024 (US Million)
7.4.3 China
7.4.3.1 China biochip market, 2013 – 2024 (US Million)
7.5 Latin America
7.5.1 Latin America biochip market, 2013 – 2024 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil biochip market, 2013 – 2024 (US Million)
7.6 MEA
7.6.1 MEA biochip market, 2013 – 2024 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa biochip market, 2013 – 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Abbott Laboratories
8.1.1 Company overview
8.1.1 Financial performance
8.1.2 Product benchmarking
8.1.3 Strategic initiatives
8.2 Agilent Technologies, Inc.
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 PerkinElmer, Inc.
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Fluidigm Corporation
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Illumina, Inc.
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 GE Healthcare
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Bio-Rad Laboratories, Inc.
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 LI-COR, Inc.
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 EMD Millipore
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
8.11 Sigma Aldrich Corporation
8.11.1 Company overview
8.11.2 Financial performance
8.11.3 Product benchmarking
8.11.4 Strategic initiatives


【レポート販売概要】

■ タイトル:バイオチップの世界市場分析:タイプ別(DNAチップ、ラボオンチップ、タンパク質チップ、がん診断および治療、遺伝子発現、一塩基多型(SNP)遺伝子型決定、ゲノミクス、薬物発見、農業バイオテクノロジー、プロテオミクス、発現プロファイリング、ハイスループットスクリーニング)、エンドユーザー別別(バイオテクノロジー・製薬企業、病院&診断センター、学術&研究機関)、セグメント予測
■ 英文:Biochip Market Analysis by Type, (DNA Chips, Lab-On-a-Chip, Protein Chips, Cancer Diagnosis and Treatment, Gene Expression, Single Nucleotide Polymorphism (SNP) Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes), and Segment Forecasts to 2024
■ 発行日:2016年8月23日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707117
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。